In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Humana Inc. (NYSE: HUM) closed the day trading at $358.57 up 0.45% from the previous closing price of $356.98. In other words, the price has increased by $0.45 from its previous closing price. On the day, 0.76 million shares were traded. HUM stock price reached its highest trading level at $360.72 during the session, while it also had its lowest trading level at $356.117.
Ratios:
For a better understanding of HUM, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on June 26, 2024, initiated with a Overweight rating and assigned the stock a target price of $392.
On June 24, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $374.
BofA Securities Downgraded its Buy to Neutral on April 02, 2024, whereas the target price for the stock was revised from $470 to $342.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 ’24 when Mesquita Jorge S. bought 545 shares for $367.09 per share. The transaction valued at 200,066 led to the insider holds 2,578 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 43172544512 and an Enterprise Value of 33574424576. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.56, and their Forward P/E ratio for the next fiscal year is 17.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 2.59. Its current Enterprise Value per Revenue stands at 0.3 whereas that against EBITDA is 7.878.
Stock Price History:
Over the past 52 weeks, HUM has reached a high of $530.54, while it has fallen to a 52-week low of $298.61. The 50-Day Moving Average of the stock is -2.44%, while the 200-Day Moving Average is calculated to be -7.04%.
Shares Statistics:
Over the past 3-months, HUM traded about 1.25M shares per day on average, while over the past 10 days, HUM traded about 710990 shares per day. A total of 122.22M shares are outstanding, with a floating share count of 119.96M. Insiders hold about 0.37% of the company’s shares, while institutions hold 97.08% stake in the company. Shares short for HUM as of 1722384000 were 2161163 with a Short Ratio of 1.72, compared to 1719532800 on 3005993. Therefore, it implies a Short% of Shares Outstanding of 2161163 and a Short% of Float of 1.7999999999999998.
Dividends & Splits
HUM’s forward annual dividend rate is 3.54, up from 3.54 a year ago. Against a Trailing Annual Dividend Yield of 0.009916522The stock’s 5-year Average Dividend Yield is 0.69.
Earnings Estimates
The current assessment of Humana Inc. (HUM) involves the perspectives of 18.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$1.32, with high estimates of $0.15 and low estimates of -$1.82.
Analysts are recommending an EPS of between $17.25 and $16.0 for the fiscal current year, implying an average EPS of $16.25. EPS for the following year is $20.02, with 21.0 analysts recommending between $21.5 and $17.87.
Revenue Estimates
14 analysts predict $28.71B in revenue for the current quarter. It ranges from a high estimate of $29.16B to a low estimate of $28.27B. As of the current estimate, Humana Inc.’s year-ago sales were $25.53BFor the next quarter, 14 analysts are estimating revenue of $28.69B. There is a high estimate of $29.17B for the next quarter, whereas the lowest estimate is $28.11B.
A total of 16 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $117.05B, while the lowest revenue estimate was $115.59B, resulting in an average revenue estimate of $116.26B. In the same quarter a year ago, actual revenue was $102.64BBased on 15 analysts’ estimates, the company’s revenue will be $117.44B in the next fiscal year. The high estimate is $125.51B and the low estimate is $112.33B.
